These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12359052)

  • 1. Allelic losses in mouse skin tumors induced by gamma-irradiation of p53 heterozygotes.
    Miyazawa T; Sato H; Hatakeyama K; Kitagawa T; Kominami R
    Jpn J Cancer Res; 2002 Sep; 93(9):994-9. PubMed ID: 12359052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of recombinant chromosomes and low fidelity of transmission of chromosome X DNA markers in gamma-ray-induced lymphomas lacking p53.
    Koide N; Matsumoto Y; Kosugi S; Chou D; Sakai K; Hatakeyama K; Niwa O; Kominami R
    Mol Carcinog; 1999 Jan; 24(1):57-63. PubMed ID: 10029411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic loss analysis of gamma-ray-induced mouse thymic lymphomas: two candidate tumor suppressor gene loci on chromosomes 12 and 16.
    Matsumoto Y; Kosugi S; Shinbo T; Chou D; Ohashi M; Wakabayashi Y; Sakai K; Okumoto M; Mori N; Aizawa S; Niwa O; Kominami R
    Oncogene; 1998 May; 16(21):2747-54. PubMed ID: 9652741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative tumor-suppressor gene regions responsible for radiation lymphomagenesis in F1 mice with different p53 status.
    Hong DP; Mori N; Umesako S; Song CW; Park YG; Aizawa S; Okumoto M
    J Radiat Res; 2002 Jun; 43(2):175-85. PubMed ID: 12238332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of genetic modifiers of thymic lymphoma development in p53-knockout mice.
    Ochiai Y; Tamura Y; Saito Y; Matsuki A; Wakabayashi Y; Aizawa Y; Niwa O; Kominami R
    Oncogene; 2003 Feb; 22(7):1098-102. PubMed ID: 12592396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent effects of UVB-induced skin carcinogenesis in hairless p53 knockout mice.
    van Kranen HJ; Westerman A; Berg RJ; Kram N; van Kreijl CF; Wester PW; de Gruijl FR
    Mutat Res; 2005 Apr; 571(1-2):81-90. PubMed ID: 15748640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of aberrant Y chromosomes in gamma-ray-induced thymic lymphomas lacking p53.
    Chou D; Matsuki J; Saitou Y; Kosugi SI; Shinbo T; Gejyo F; Niwa O; Kominami R
    Mol Carcinog; 1999 Nov; 26(3):157-62. PubMed ID: 10559790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic loss mapping and physical delineation of a region harboring a putative thymic lymphoma suppressor gene on mouse chromosome 12.
    Shinbo T; Matsuki A; Matsumoto Y; Kosugi S; Takahashi Y; Niwa O; Kominami R
    Oncogene; 1999 Jul; 18(28):4131-6. PubMed ID: 10435594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic loss analysis of lymphomas induced in Fas-heterozygous deficient mice.
    Ogawa S; Hong DP; Mori N; Umesako S; Song CW; Okumoto M
    J Vet Med Sci; 2004 Jan; 66(1):97-102. PubMed ID: 14960823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity.
    Kanjilal S; Pierceall WE; Cummings KK; Kripke ML; Ananthaswamy HN
    Cancer Res; 1993 Jul; 53(13):2961-4. PubMed ID: 8319202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
    Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
    Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
    Umesako S; Fujisawa K; Iiga S; Mori N; Takahashi M; Hong DP; Song CW; Haga S; Imai S; Niwa O; Okumoto M
    Breast Cancer Res; 2005; 7(1):R164-70. PubMed ID: 15642165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation.
    Li G; Tron V; Ho V
    J Invest Dermatol; 1998 Jan; 110(1):72-5. PubMed ID: 9424091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct pattern of allelic loss and inactivation of cadherin 1 and 5 genes in mammary carcinomas arising in p53(+/-) mice.
    Umesako S; Iiga S; Takahashi M; Imura K; Mori N; Hong DP; Song CW; Niwa O; Okumoto M
    J Radiat Res; 2007 Mar; 48(2):143-52. PubMed ID: 17327688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity.
    Rebel H; Mosnier LO; Berg RJ; Westerman-de Vries A; van Steeg H; van Kranen HJ; de Gruijl FR
    Cancer Res; 2001 Feb; 61(3):977-83. PubMed ID: 11221893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogenic alterations in murine liver, lung, and uterine tumors induced by in utero exposure to ionizing radiation.
    Lumniczky K; Antal S; Unger E; Wunderlich L; Hidvégi EJ; Sáfrány G
    Mol Carcinog; 1998 Feb; 21(2):100-10. PubMed ID: 9496910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Bcl11b genotypes and gamma-radiation on the development of mouse thymic lymphomas.
    Yoshikai Y; Sato T; Morita S; Kohara Y; Takagi R; Mishima Y; Kominami R
    Biochem Biophys Res Commun; 2008 Aug; 373(2):282-5. PubMed ID: 18558082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 protects against skin cancer induction by UV-B radiation.
    Jiang W; Ananthaswamy HN; Muller HK; Kripke ML
    Oncogene; 1999 Jul; 18(29):4247-53. PubMed ID: 10435637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity on chromosome 5 in vicinity of the telomere in gamma-radiation-induced thymic lymphomas in mice.
    Sitarz M; Wirth-Dzieciolowska E; Demant P
    Neoplasma; 2000; 47(3):148-50. PubMed ID: 11043836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma.
    Gailani MR; Leffell DJ; Ziegler A; Gross EG; Brash DE; Bale AE
    J Natl Cancer Inst; 1996 Mar; 88(6):349-54. PubMed ID: 8609643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.